Next, we used OVA to mimic a tumor antigen and devised a vector allowing the inducible expression of cytosolic OVA with constitutive expression of Myc. We introduced this vector alongside the CRISPR Trp53/Pten deletion vector into Chat-GFP; OT-II mice (Fig. 4h). The gene discussed is MYC; the disease is neoplasm.